Skip to main content
. Author manuscript; available in PMC: 2018 Jul 13.
Published in final edited form as: J Med Chem. 2017 Jun 26;60(13):5556–5585. doi: 10.1021/acs.jmedchem.7b00239

Table 3.

Optimization of potency based on substituent placement and identity of A-ring.

graphic file with name nihms958792u4.jpg
I30μM / Icontrol (mean ± SEM, %) EC50 (max.) (μM %)a
# R1 R2 R3 R4 GluN2B GluN2C GluN2D GluN2B GluN2C GluN2D
95 H H H H 88 ± 1.1 83 ± 2.5 69 ± 2.3 -- -- --
92b H Cl H H 145 ± 7.8 126 ± 2.8 102 ± 2.0 5.3 (158%) 1.8 (128%) --
96 H Br H H 136 ± 7.9 133 ± 5.1 98 ± 1.9 3.4 (137%) 1.8 (135%) --
97 H F H H 147 ± 3.7 104 ± 2.2 91 ± 1.7 7.2 (152%) -- --
98 H CF3 H H 124 ± 7.0 129 ± 3.8 95 ± 8.6 2.4 (124%) 1.3 (130%) --
99 H Ph H H 112 ± 4.4 92 ± 3.7 92 ± 1.9 -- -- --
100 H Me H H 78 ± 1.2 67 ± 2.1 43 ± 2.3 -- -- --
101 H OMe H H 89 ± 5.1 65 ± 4.1 44 ± 4.5 -- -- --
102 F H H H 61 ± 2.4 68 ± 4.1 55 ± 4.5 -- -- --
103 Cl H H H 67 ± 4.1 93 ± 6.3 79 ± 3.4 -- -- --
104 H H F H 118 ± 5.8 107 ± 6.7 90 ± 3.7 -- -- --
105 H H Cl H 112 ± 2.1 101 ± 7.8 88 ± 7.7 -- -- --
106 H F F H 172 ± 6.0 145 ± 6.6 133 ± 3.7 3.7 (173%) 1.8 (150%) 2.9 (137%)
107c H Cl Cl H 133 ± 5.3 150 ± 8.1 122 ± 4.1 ND ND ND
108 H Cl F H 169 ± 7.8 159 ± 6.3 133 ± 4.8 2.2 (170%) 1.3 (162%) 2.2 (137%)
109c H Cl H Cl 105 ± 3.3 97 ± 2.9 80 ± 3.0 -- -- --
a

Fitted EC50 values are shown to two significant figures when potentiation at 30 μM exceeded 120%; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) current. Data are from between 6–17 oocytes from 2–3 frogs for each compound and receptor tested.

b

Compound 92 from Table 1 is included here for comparison.

c

Current ratio reported is for 3 μM (compound 107) or 10 μM (compounds 99, 109) because these compounds were not soluble at 10 or 30 μM, respectively.

ND (not determined) indicates that we could not obtain data at high enough concentrations to determine a fitted maximum value for the concentration-effect curve.